» Articles » PMID: 26165028

[Molecular Pathology of Colon Cancer]

Overview
Journal Pol J Pathol
Specialty Pathology
Date 2015 Jul 14
PMID 26165028
Citations 4
Authors
Affiliations
Soon will be listed here.
Citing Articles

Analysis of molecular and clinical parameters of 4-year adalimumab therapy in psoriatic patients.

Wcislo-Dziadecka D, Grabarek B, Kruszniewska-Rajs C, Swinarew A, Jasik K, Rozwadowska B Postepy Dermatol Alergol. 2020; 37(5):736-745.

PMID: 33240014 PMC: 7675078. DOI: 10.5114/ada.2020.100484.


Comprehensive molecular and clinical analysis of adalimumab and etanercept therapeutic potential in patients with psoriatic arthritis.

Wcislo-Dziadecka D, Grabarek B, Swinarew A, Rozwadowska B, Zmarzly N, Gola J Postepy Dermatol Alergol. 2020; 37(2):262-268.

PMID: 32489364 PMC: 7262816. DOI: 10.5114/ada.2020.94847.


Scutellarein inhibits the development of colon cancer via CDC4‑mediated RAGE ubiquitination.

Li Y, Wang J, Zhong S, Li J, Du W Int J Mol Med. 2020; 45(4):1059-1072.

PMID: 32124957 PMC: 7053863. DOI: 10.3892/ijmm.2020.4496.


Conventional colon adenomas harbor various disturbances in microsatellite stability and contain micro-serrated foci with microsatellite instability.

Lewitowicz P, Gluszek S, Koziel D, Horecka-Lewitowicz A, Chrapek M, Wolak P PLoS One. 2017; 12(2):e0172381.

PMID: 28234922 PMC: 5325232. DOI: 10.1371/journal.pone.0172381.